Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
APHD-012 by Aphaia Pharma for Pre-Diabetes/Impaired Glucose Tolerance: Likelihood of Approval
APHD-012 is under clinical development by Aphaia Pharma and currently in Phase II for Pre-Diabetes/Impaired Glucose Tolerance. According to GlobalData,...